AGP Wire

AGP

The market for neonatal infants enteral feeding devices is projected to grow from $2.23 billion in 2025 to $2.59 billion by 2030, driven by preterm births, NICU demand and broader neonatal care adoption.

AGP

The Business Research Company says the global neurology devices market is on track to grow from $20.09 billion in 2025 to $35.94 billion by 2030, driven by rising neurological disease rates, new imaging tools and wider use of minimally invasive…

AGP

The Business Research Company says the global neurointerventional devices market is on track to grow from $2.76 billion in 2025 to $3.91 billion by 2030, driven by stroke, aneurysm and aging-population demand.

AGP

The neuroendoscopy market is projected to grow from $0.83 billion in 2026 to $1.09 billion by 2030, according to The Business Research Company.

AGP

The neuromodulation market is projected to grow from $8.45 billion in 2026 to $12.88 billion by 2030, according to The Business Research Company.

AGP

The nasal drug delivery technology market is projected to grow from $92.28 billion in 2026 to $129.23 billion by 2030, driven by demand for faster, non-invasive therapies and more work in CNS drugs and vaccines.

AGP

The nephrostomy bags market is projected to rise from $1.16 billion in 2025 to $1.25 billion in 2026, then reach $1.65 billion by 2030, according to The Business Research Company.

AGP

The neonatal point-of-care testing market is projected to rise from $1.52 billion in 2026 to $2.59 billion by 2030, driven by demand for faster newborn diagnostics, remote monitoring and portable testing tools.

AGP

The Business Research Company says the narcotics scanner market is expanding as drug trafficking, public safety concerns and border security spending rise.

AGP

The nasal splints market is projected to grow from $7.07 billion in 2025 to $10.76 billion by 2030, driven by more nasal and septal surgeries, cosmetic rhinoplasty and demand for minimally invasive procedures.

AGP

The global needle market is projected to grow from $8.82 billion in 2025 to $9.5 billion in 2026, driven by vaccination, injectable therapies, chronic disease care and more clinical procedures.

AGP

The neurophysiology devices and equipment market is projected to grow from $1.76 billion in 2026 to $2.51 billion by 2030, driven by rising neurological disease rates, more point-of-care diagnostics and wider use of portable and wireless systems….

AGP

The Business Research Company projects the global minimally invasive surgery market will grow from $76.41 billion in 2026 to $108.09 billion by 2030, driven by robotic surgery, image-guided procedures and outpatient care.

AGP

The Business Research Company says the neuroscience antibodies and assays market is set to expand from $5.76 billion in 2026 to $9.83 billion by 2030, driven by rising neurological disease rates, research spending and demand for automated…

AGP

The Business Research Company says the NGS-based RNA-sequencing market will rise from $4.2 billion in 2025 to $12.73 billion by 2030, driven by precision medicine, pharmaceutical research and broader clinical use. North America led the market in…

AGP

The next-generation sequencing informatics market is projected to grow from $11.96 billion in 2026 to $22.14 billion by 2030, driven by personalized medicine, cloud-based genomic platforms and AI tools.

AGP

The neurovascular catheters market is projected to grow from $4.87 billion in 2025 to $8.17 billion by 2030, driven by rising stroke treatment needs, an aging population and broader use of minimally invasive procedures.

AGP

The next-generation mass spectrometer market is projected to grow from $3.6 billion in 2025 to $5.75 billion by 2030, driven by demand for higher sensitivity, AI-enabled analysis and broader use in clinical, environmental and food testing.

AGP

The mobile C-arm market is projected to grow from $1.42 billion in 2025 to $2.01 billion by 2030, driven by more image-guided surgery, ambulatory surgical centers and demand for portable imaging.

AGP

The Business Research Company says the mobility aid medical device market is growing on aging populations, injuries, and wider use of rehab and home care.